Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) [U54]

The summary for the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) [U54] Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) [U54]
	CFDA Number:	93.856
	CFDA Description:	Microbiology and Infectious Diseases Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-AI-08-002
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Dec 21, 2007
	Creation Date:	Dec 21, 2007
	Original Closing Date for Applications:	Jun 03, 2008
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Jul 04, 2008
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$91,000,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses
Additional Information on Eligibility: Foreign institutions are not eligible to apply.
Grant Description: Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to continue support for the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program. The overall goal of the RCE Program is to establish and maintain strong infrastructure and multifaceted research and development activities to provide scientific information and translational research capacity that will facilitate the next generation of therapeutics, diagnostics and vaccines against the NIAID Category A-C Priority Pathogens (http://www3.niaid.nih.gov/topics/BiodefenseRelated/Biodefense/default.htm) and emerging infectious diseases (EID) agents (http://www3.niaid.nih.gov/research/topics/emerging/list.htm). Mechanism of Support: This FOA will use the NIH Specialized Centers Cooperative Agreement funding mechanism (U54). Funds Available and Anticipated Number of Awards: The NIAID expects to commit approximately $91 million in FY 2009 to support up to 10 awards in the range of $3 million to 12 million direct costs per year each. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-08-002.html http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-08-002.html
Grant Announcement Contact: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Biomedical Prevention of HIV Research Education (R25); • Partnerships for Next Generation Biodefense Diagnostics (R01); • National Biocontainment Laboratories (NBLs) Operations Support Limited Competition (UC7); • Partnerships for Development of New Therapeutic Classes for Select Viral and Bacterial Pathogens (R0...; • Non-Antibiotic Selectable Markers for Biodefense (R21); • Partnerships to Improve Diagnosis and Treatment of Selected Drug-Resistant Healthcare-Associated Inf...; • Cooperative Research Partnerships for Biodefense (U01); • Pharmacological Approaches to Combating Antimicrobial Resistance (R01); • Cooperative Research Partnerships for Biodefense and Emerging Infectious Diseases (U01)